Publication | Closed Access

High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin

Modified Folfox6OncologyAllergyMedicineHigh-dose DexamethasonePharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyCancer ResearchHypersensitivity Reactions